Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

Passive inhalation of dry powder influenza vaccine formulations completely protects chickens against H5N1 lethal viral challenge.

Tomar J, Biel C, de Haan CAM, Rottier PJM, Petrovsky N, Frijlink HW, Huckriede A, Hinrichs WLJ, Peeters B.

Eur J Pharm Biopharm. 2018 Dec;133:85-95. doi: 10.1016/j.ejpb.2018.10.008. Epub 2018 Oct 9.

2.

Deletion of accessory genes 3a, 3b, 5a or 5b from avian coronavirus infectious bronchitis virus induces an attenuated phenotype both in vitro and in vivo.

Laconi A, van Beurden SJ, Berends AJ, Krämer-Kühl A, Jansen CA, Spekreijse D, Chénard G, Philipp HC, Mundt E, Rottier PJM, Hélène Verheije M.

J Gen Virol. 2018 Aug 1. doi: 10.1099/jgv.0.001130. [Epub ahead of print]

PMID:
30067172
3.

Differential susceptibility of macrophages to serotype II feline coronaviruses correlates with differences in the viral spike protein.

Shirato K, Chang HW, Rottier PJM.

Virus Res. 2018 Aug 15;255:14-23. doi: 10.1016/j.virusres.2018.06.010. Epub 2018 Jun 21.

PMID:
29936068
4.

Recombinant live attenuated avian coronavirus vaccines with deletions in the accessory genes 3ab and/or 5ab protect against infectious bronchitis in chickens.

van Beurden SJ, Berends AJ, Krämer-Kühl A, Spekreijse D, Chenard G, Philipp HC, Mundt E, Rottier PJM, Verheije MH.

Vaccine. 2018 Feb 14;36(8):1085-1092. doi: 10.1016/j.vaccine.2018.01.017.

5.

A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion.

Guardado-Calvo P, Atkovska K, Jeffers SA, Grau N, Backovic M, Pérez-Vargas J, de Boer SM, Tortorici MA, Pehau-Arnaudet G, Lepault J, England P, Rottier PJ, Bosch BJ, Hub JS, Rey FA.

Science. 2017 Nov 3;358(6363):663-667. doi: 10.1126/science.aal2712.

PMID:
29097548
6.

A reverse genetics system for avian coronavirus infectious bronchitis virus based on targeted RNA recombination.

van Beurden SJ, Berends AJ, Krämer-Kühl A, Spekreijse D, Chénard G, Philipp HC, Mundt E, Rottier PJM, Verheije MH.

Virol J. 2017 Jun 12;14(1):109. doi: 10.1186/s12985-017-0775-8.

7.

Cell Attachment Domains of the Porcine Epidemic Diarrhea Virus Spike Protein Are Key Targets of Neutralizing Antibodies.

Li C, Li W, Lucio de Esesarte E, Guo H, van den Elzen P, Aarts E, van den Born E, Rottier PJM, Bosch BJ.

J Virol. 2017 May 26;91(12). pii: e00273-17. doi: 10.1128/JVI.00273-17. Print 2017 Jun 15.

8.

Aminopeptidase N is not required for porcine epidemic diarrhea virus cell entry.

Li W, Luo R, He Q, van Kuppeveld FJM, Rottier PJM, Bosch BJ.

Virus Res. 2017 May 2;235:6-13. doi: 10.1016/j.virusres.2017.03.018. Epub 2017 Mar 28.

PMID:
28363778
9.

Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: Consequences for vaccine strain selection.

Peeters B, Reemers S, Dortmans J, de Vries E, de Jong M, van de Zande S, Rottier PJM, de Haan CAM.

Virology. 2017 Mar;503:83-93. doi: 10.1016/j.virol.2017.01.012. Epub 2017 Jan 28.

10.

Crucial steps in the structure determination of a coronavirus spike glycoprotein using cryo-electron microscopy.

Walls A, Tortorici MA, Bosch BJ, Frenz B, Rottier PJ, DiMaio F, Rey FA, Veesler D.

Protein Sci. 2017 Jan;26(1):113-121. doi: 10.1002/pro.3048. Epub 2016 Oct 18.

11.

Cellular entry of the porcine epidemic diarrhea virus.

Li W, van Kuppeveld FJM, He Q, Rottier PJM, Bosch BJ.

Virus Res. 2016 Dec 2;226:117-127. doi: 10.1016/j.virusres.2016.05.031. Epub 2016 Jun 15. Review.

12.

Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.

Widjaja I, Wicht O, Luytjes W, Leenhouts K, Rottier PJM, van Kuppeveld FJM, Haijema BJ, de Haan CAM.

J Virol. 2016 Jun 10;90(13):5965-5977. doi: 10.1128/JVI.00235-16. Print 2016 Jul 1.

13.

Coronavirus: epidemiology, genome replication and the interactions with their hosts.

Shi ZL, Guo D, Rottier PJ.

Virol Sin. 2016 Feb;31(1):1-2. doi: 10.1007/s12250-016-3746-0. No abstract available.

PMID:
26908210
14.

Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer.

Walls AC, Tortorici MA, Bosch BJ, Frenz B, Rottier PJM, DiMaio F, Rey FA, Veesler D.

Nature. 2016 Mar 3;531(7592):114-117. doi: 10.1038/nature16988. Epub 2016 Feb 8.

15.

Budded baculovirus particle structure revisited.

Wang Q, Bosch BJ, Vlak JM, van Oers MM, Rottier PJ, van Lent JWM.

J Invertebr Pathol. 2016 Feb;134:15-22. doi: 10.1016/j.jip.2015.12.001. Epub 2015 Dec 29.

PMID:
26743500
16.

Recombinant Soluble Respiratory Syncytial Virus F Protein That Lacks Heptad Repeat B, Contains a GCN4 Trimerization Motif and Is Not Cleaved Displays Prefusion-Like Characteristics.

Widjaja I, Rigter A, Jacobino S, van Kuppeveld FJ, Leenhouts K, Palomo C, Melero JA, Leusen JH, Haijema BJ, Rottier PJ, de Haan CA.

PLoS One. 2015 Jun 24;10(6):e0130829. doi: 10.1371/journal.pone.0130829. eCollection 2015.

17.

A Single Point Mutation Creating a Furin Cleavage Site in the Spike Protein Renders Porcine Epidemic Diarrhea Coronavirus Trypsin Independent for Cell Entry and Fusion.

Li W, Wicht O, van Kuppeveld FJ, He Q, Rottier PJ, Bosch BJ.

J Virol. 2015 Aug;89(15):8077-81. doi: 10.1128/JVI.00356-15. Epub 2015 May 13.

18.

Rapid Emergence of Highly Pathogenic Avian Influenza Subtypes from a Subtype H5N1 Hemagglutinin Variant.

de Vries E, Guo H, Dai M, Rottier PJ, van Kuppeveld FJ, de Haan CA.

Emerg Infect Dis. 2015 May;21(5):842-6. doi: 10.3201/eid2105.141927.

19.

A field-proven yeast two-hybrid protocol used to identify coronavirus-host protein-protein interactions.

Vidalain PO, Jacob Y, Hagemeijer MC, Jones LM, Neveu G, Roussarie JP, Rottier PJ, Tangy F, de Haan CA.

Methods Mol Biol. 2015;1282:213-29. doi: 10.1007/978-1-4939-2438-7_18.

PMID:
25720483
20.

ATP1A1-mediated Src signaling inhibits coronavirus entry into host cells.

Burkard C, Verheije MH, Haagmans BL, van Kuppeveld FJ, Rottier PJ, Bosch BJ, de Haan CA.

J Virol. 2015 Apr;89(8):4434-48. doi: 10.1128/JVI.03274-14. Epub 2015 Feb 4.

21.

Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner.

Burkard C, Verheije MH, Wicht O, van Kasteren SI, van Kuppeveld FJ, Haagmans BL, Pelkmans L, Rottier PJ, Bosch BJ, de Haan CA.

PLoS Pathog. 2014 Nov 6;10(11):e1004502. doi: 10.1371/journal.ppat.1004502. eCollection 2014 Nov. Erratum in: PLoS Pathog. 2015 Feb;11(2):e1004709.

22.

Dissecting virus entry: replication-independent analysis of virus binding, internalization, and penetration using minimal complementation of β-galactosidase.

Burkard C, Bloyet LM, Wicht O, van Kuppeveld FJ, Rottier PJ, de Haan CA, Bosch BJ.

PLoS One. 2014 Jul 15;9(7):e101762. doi: 10.1371/journal.pone.0101762. eCollection 2014.

23.

A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice.

Koraka P, Bosch BJ, Cox M, Chubet R, Amerongen Gv, Lövgren-Bengtsson K, Martina BE, Roose J, Rottier PJ, Osterhaus AD.

Vaccine. 2014 Aug 6;32(36):4644-50. doi: 10.1016/j.vaccine.2014.06.058. Epub 2014 Jun 21.

PMID:
24962755
24.

Membrane rearrangements mediated by coronavirus nonstructural proteins 3 and 4.

Hagemeijer MC, Monastyrska I, Griffith J, van der Sluijs P, Voortman J, van Bergen en Henegouwen PM, Vonk AM, Rottier PJ, Reggiori F, de Haan CA.

Virology. 2014 Jun;458-459:125-35. doi: 10.1016/j.virol.2014.04.027. Epub 2014 May 13.

25.

Proteolytic activation of the porcine epidemic diarrhea coronavirus spike fusion protein by trypsin in cell culture.

Wicht O, Li W, Willems L, Meuleman TJ, Wubbolts RW, van Kuppeveld FJ, Rottier PJ, Bosch BJ.

J Virol. 2014 Jul;88(14):7952-61. doi: 10.1128/JVI.00297-14. Epub 2014 May 7.

26.

Identification and characterization of a proteolytically primed form of the murine coronavirus spike proteins after fusion with the target cell.

Wicht O, Burkard C, de Haan CA, van Kuppeveld FJ, Rottier PJ, Bosch BJ.

J Virol. 2014 May;88(9):4943-52. doi: 10.1128/JVI.03451-13. Epub 2014 Feb 19.

27.

Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013.

Reusken CB, Ababneh M, Raj VS, Meyer B, Eljarah A, Abutarbush S, Godeke GJ, Bestebroer TM, Zutt I, Muller MA, Bosch BJ, Rottier PJ, Osterhaus AD, Drosten C, Haagmans BL, Koopmans MP.

Euro Surveill. 2013 Dec 12;18(50):20662.

28.

Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus.

Raj VS, Smits SL, Provacia LB, van den Brand JM, Wiersma L, Ouwendijk WJ, Bestebroer TM, Spronken MI, van Amerongen G, Rottier PJ, Fouchier RA, Bosch BJ, Osterhaus AD, Haagmans BL.

J Virol. 2014 Feb;88(3):1834-8. doi: 10.1128/JVI.02935-13. Epub 2013 Nov 20.

29.

Adaptation of novel H7N9 influenza A virus to human receptors.

Dortmans JC, Dekkers J, Wickramasinghe IN, Verheije MH, Rottier PJ, van Kuppeveld FJ, de Vries E, de Haan CA.

Sci Rep. 2013 Oct 28;3:3058. doi: 10.1038/srep03058.

30.

Evolution of the hemagglutinin protein of the new pandemic H1N1 influenza virus: maintaining optimal receptor binding by compensatory substitutions.

de Vries RP, de Vries E, Martínez-Romero C, McBride R, van Kuppeveld FJ, Rottier PJ, García-Sastre A, Paulson JC, de Haan CA.

J Virol. 2013 Dec;87(24):13868-77. doi: 10.1128/JVI.01955-13. Epub 2013 Oct 9.

31.

A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles.

Rigter A, Widjaja I, Versantvoort H, Coenjaerts FE, van Roosmalen M, Leenhouts K, Rottier PJ, Haijema BJ, de Haan CA.

PLoS One. 2013 Aug 12;8(8):e71072. doi: 10.1371/journal.pone.0071072. eCollection 2013.

32.

Manipulation of the porcine epidemic diarrhea virus genome using targeted RNA recombination.

Li C, Li Z, Zou Y, Wicht O, van Kuppeveld FJ, Rottier PJ, Bosch BJ.

PLoS One. 2013 Aug 2;8(8):e69997. doi: 10.1371/journal.pone.0069997. Print 2013.

33.

The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies.

Mou H, Raj VS, van Kuppeveld FJ, Rottier PJ, Haagmans BL, Bosch BJ.

J Virol. 2013 Aug;87(16):9379-83. doi: 10.1128/JVI.01277-13. Epub 2013 Jun 19.

34.

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.

Raj VS, Mou H, Smits SL, Dekkers DH, Müller MA, Dijkman R, Muth D, Demmers JA, Zaki A, Fouchier RA, Thiel V, Drosten C, Rottier PJ, Osterhaus AD, Bosch BJ, Haagmans BL.

Nature. 2013 Mar 14;495(7440):251-4. doi: 10.1038/nature12005.

PMID:
23486063
35.

Genome-wide gene expression analysis of anguillid herpesvirus 1.

van Beurden SJ, Peeters BP, Rottier PJ, Davison AJ, Engelsma MY.

BMC Genomics. 2013 Feb 6;14:83. doi: 10.1186/1471-2164-14-83.

36.

Biogenesis and dynamics of the coronavirus replicative structures.

Hagemeijer MC, Rottier PJ, de Haan CA.

Viruses. 2012 Nov 21;4(11):3245-69. doi: 10.3390/v4113245. Review.

37.

An autophagy-independent role for LC3 in equine arteritis virus replication.

Monastyrska I, Ulasli M, Rottier PJ, Guan JL, Reggiori F, de Haan CA.

Autophagy. 2013 Feb 1;9(2):164-74. doi: 10.4161/auto.22743. Epub 2012 Nov 26.

38.

European surveillance for pantropic canine coronavirus.

Decaro N, Cordonnier N, Demeter Z, Egberink H, Elia G, Grellet A, Le Poder S, Mari V, Martella V, Ntafis V, von Reitzenstein M, Rottier PJ, Rusvai M, Shields S, Xylouri E, Xu Z, Buonavoglia C.

J Clin Microbiol. 2013 Jan;51(1):83-8. doi: 10.1128/JCM.02466-12. Epub 2012 Oct 24.

39.

Competition between influenza A virus genome segments.

Widjaja I, de Vries E, Rottier PJ, de Haan CA.

PLoS One. 2012;7(10):e47529. doi: 10.1371/journal.pone.0047529. Epub 2012 Oct 11.

40.

Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein.

de Boer SM, Kortekaas J, Spel L, Rottier PJ, Moormann RJ, Bosch BJ.

J Virol. 2012 Dec;86(24):13642-52. doi: 10.1128/JVI.01973-12. Epub 2012 Oct 3.

41.

Heparan sulfate facilitates Rift Valley fever virus entry into the cell.

de Boer SM, Kortekaas J, de Haan CA, Rottier PJ, Moormann RJ, Bosch BJ.

J Virol. 2012 Dec;86(24):13767-71. doi: 10.1128/JVI.01364-12. Epub 2012 Sep 26.

42.

Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice.

Cornelissen LA, de Leeuw OS, Tacken MG, Klos HC, de Vries RP, de Boer-Luijtze EA, van Zoelen-Bos DJ, Rigter A, Rottier PJ, Moormann RJ, de Haan CA.

PLoS One. 2012;7(8):e44447. doi: 10.1371/journal.pone.0044447. Epub 2012 Aug 28.

43.

Glycan-dependent immunogenicity of recombinant soluble trimeric hemagglutinin.

de Vries RP, Smit CH, de Bruin E, Rigter A, de Vries E, Cornelissen LA, Eggink D, Chung NP, Moore JP, Sanders RW, Hokke CH, Koopmans M, Rottier PJ, de Haan CA.

J Virol. 2012 Nov;86(21):11735-44. doi: 10.1128/JVI.01084-12. Epub 2012 Aug 22.

44.

Anguillid herpesvirus 1 transcriptome.

van Beurden SJ, Gatherer D, Kerr K, Galbraith J, Herzyk P, Peeters BP, Rottier PJ, Engelsma MY, Davison AJ.

J Virol. 2012 Sep;86(18):10150-61. doi: 10.1128/JVI.01271-12. Epub 2012 Jul 11.

45.

Spike protein fusion peptide and feline coronavirus virulence.

Chang HW, Egberink HF, Halpin R, Spiro DJ, Rottier PJ.

Emerg Infect Dis. 2012 Jul;18(7):1089-95. doi: 10.3201/eid1807.120143.

46.

CD200 receptor controls sex-specific TLR7 responses to viral infection.

Karnam G, Rygiel TP, Raaben M, Grinwis GC, Coenjaerts FE, Ressing ME, Rottier PJ, de Haan CA, Meyaard L.

PLoS Pathog. 2012;8(5):e1002710. doi: 10.1371/journal.ppat.1002710. Epub 2012 May 17.

47.

Single-cell analysis of population context advances RNAi screening at multiple levels.

Snijder B, Sacher R, Rämö P, Liberali P, Mench K, Wolfrum N, Burleigh L, Scott CC, Verheije MH, Mercer J, Moese S, Heger T, Theusner K, Jurgeit A, Lamparter D, Balistreri G, Schelhaas M, De Haan CA, Marjomäki V, Hyypiä T, Rottier PJ, Sodeik B, Marsh M, Gruenberg J, Amara A, Greber U, Helenius A, Pelkmans L.

Mol Syst Biol. 2012 Apr 24;8:579. doi: 10.1038/msb.2012.9.

48.

Influenza A virus entry into cells lacking sialylated N-glycans.

de Vries E, de Vries RP, Wienholts MJ, Floris CE, Jacobs MS, van den Heuvel A, Rottier PJ, de Haan CA.

Proc Natl Acad Sci U S A. 2012 May 8;109(19):7457-62. doi: 10.1073/pnas.1200987109. Epub 2012 Apr 23.

49.

Visualizing coronavirus RNA synthesis in time by using click chemistry.

Hagemeijer MC, Vonk AM, Monastyrska I, Rottier PJ, de Haan CA.

J Virol. 2012 May;86(10):5808-16. doi: 10.1128/JVI.07207-11. Epub 2012 Mar 21.

50.

Expression of epidermal growth factor receptor in canine osteosarcoma: association with clinicopathological parameters and prognosis.

Selvarajah GT, Verheije MH, Kik M, Slob A, Rottier PJ, Mol JA, Kirpensteijn J.

Vet J. 2012 Aug;193(2):412-9. doi: 10.1016/j.tvjl.2012.02.009. Epub 2012 Mar 19.

PMID:
22436430

Supplemental Content

Loading ...
Support Center